NASDAQ:ADUS

Addus HomeCare (ADUS) Stock Forecast, Price & News

$85.19

-0.97 (-1.13%)

(As of 09/29/2023 ET)

Compare

Today's Range: $85.08
▼
$86.32
50-Day Range: $82.88
▼
$96.30
52-Week Range: $77.30
▼
$114.99

Volume: 94,274 shs
Average Volume: 74,344 shs
Market Capitalization: $1.38 billion

P/E Ratio: 25.74
Dividend Yield: N/A
Price Target: $110.50

Addus HomeCare MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 29.7% Upside
$110.50 Price Target
Short Interest: Healthy
1.99% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.50
Upright™ Environmental Score
News Sentiment: 0.82
Based on 5 Articles This Week
Insider Trading: Selling Shares
$3.28 M Sold Last Quarter
Proj. Earnings Growth: 11.64%
From $3.78 to $4.22 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.92 out of 5 stars

Medical Sector

43rd out of 970 stocks

Home Health Care Services Industry

3rd out of 7 stocks

3.5

Analyst's Opinion

Consensus Rating
Addus HomeCare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $110.50, Addus HomeCare has a forecasted upside of 29.7% from its current price of $85.19.
Amount of Analyst Coverage
Addus HomeCare has only been the subject of 3 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.99% of the outstanding shares of Addus HomeCare have been sold short.
Short Interest Ratio / Days to Cover
Addus HomeCare has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Addus HomeCare has recently increased by 10.59%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Addus HomeCare does not currently pay a dividend.
Dividend Growth
Addus HomeCare does not have a long track record of dividend growth.

5.0

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Addus HomeCare has received a 85.99% net impact score from Upright. The largest positive contribution comes from its "Meaning & joy" impact, which is mostly driven by its "Private hospice care", "Private occupational therapy services", and "Private home care for the elderly" products. See details.
Environmental Sustainability
The Environmental Impact score for Addus HomeCare is -0.50.

3.2

News and Social Media Coverage

News Sentiment
Addus HomeCare has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Addus HomeCare this week, compared to 3 articles on an average week.
Search Interest
Only 2 people have searched for ADUS on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
2 people have added Addus HomeCare to their MarketBeat watchlist in the last 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Addus HomeCare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,279,405.00 in company stock.
Percentage Held by Insiders
Only 4.40% of the stock of Addus HomeCare is held by insiders.
Percentage Held by Institutions
95.26% of the stock of Addus HomeCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Addus HomeCare are expected to grow by 11.64% in the coming year, from $3.78 to $4.22 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Addus HomeCare is 25.74, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.93.
Price to Earnings Ratio vs. Sector
The P/E ratio of Addus HomeCare is 25.74, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 108.16.
Price to Earnings Growth Ratio
Addus HomeCare has a PEG Ratio of 1.80. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Addus HomeCare has a P/B Ratio of 2.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

ADUS Price History

30 days | 90 days | 365 days | Advanced Chart

ADUS Stock News Headlines

September 25, 2023 | finance.yahoo.com

Here’s Why Addus HomeCare Corporation (ADUS) Sold-Off in Q2

September 19, 2023 | stocknews.com

3 Medical Stocks Generating Buzz Among Investors

September 30, 2023 | Chaikin Analytics (Ad)

Get Your Cash Out of U.S. Banks Immediately

Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making. Click here to learn more.

September 18, 2023 | stocknews.com

Wall Street Buys: 3 'A' Rated Medical Stocks

September 16, 2023 | seekingalpha.com

Addus HomeCare: More Challenges To Think About With CMS Proposals

August 22, 2023 | finance.yahoo.com

What Is Addus HomeCare Corporation's (NASDAQ:ADUS) Share Price Doing?

August 3, 2023 | msn.com

Stephens & Co. Maintains Addus HomeCare (ADUS) Overweight Recommendation

August 2, 2023 | finance.yahoo.com

Addus HomeCare Corp (ADUS): A Healthcare Provider with High Outperformance Potential

September 30, 2023 | Altimetry (Ad)

Pentagon Consultant—Here's how Biden Wins Landslide Re-election

—but also hand Joe Biden a landslide re-election win. What would America look like if we slide further towards Socialism? Full story and 4 steps you can take,

August 1, 2023 | markets.businessinsider.com

The Latest Analyst Ratings for Addus HomeCare

August 1, 2023 | finance.yahoo.com

Addus HomeCare Completes Acquisition of Tennessee Quality Care Operations

July 31, 2023 | finance.yahoo.com

Addus HomeCare Announces Second Quarter 2023 Financial Results

July 31, 2023 | finance.yahoo.com

Addus HomeCare (ADUS) Q2 Earnings and Revenues Beat Estimates

July 23, 2023 | finance.yahoo.com

Addus HomeCare's (NASDAQ:ADUS) Returns Have Hit A Wall

July 20, 2023 | finance.yahoo.com

Why Addus HomeCare (ADUS) Could Beat Earnings Estimates Again

July 17, 2023 | finance.yahoo.com

Addus HomeCare Announces Second Quarter 2023 Earnings Release and Conference Call

July 1, 2023 | msn.com

Addus HomeCare: Economic Troubles Remain Well In Situ, Reiterate Hold

June 29, 2023 | markets.businessinsider.com

Analyst Expectations for Addus HomeCare's Future

June 29, 2023 | finance.yahoo.com

Addus HomeCare Expands Tennessee Home Care Presence With Agreement to Acquire Tennessee Quality Care Operations

June 6, 2023 | finance.yahoo.com

Thermo Fisher's (TMO) Unveils Orbitrap Astral Spectrometer

May 29, 2023 | msn.com

Wall Street Analysts Predict a 28.56% Upside in Addus HomeCare (ADUS): Here's What You Should Know

May 29, 2023 | finance.yahoo.com

Wall Street Analysts Predict a 28.56% Upside in Addus HomeCare (ADUS): Here's What You Should Know

May 27, 2023 | msn.com

Oppenheimer Reiterates Addus HomeCare (ADUS) Outperform Recommendation

May 26, 2023 | markets.businessinsider.com

Oppenheimer Keeps Their Buy Rating on Addus Homecare (ADUS)

May 26, 2023 | finance.yahoo.com

Medtronic (MDT) to Expand Diabetes Care With New Buyout

May 26, 2023 | fool.com

Addus HomeCare (NASDAQ: ADUS)

May 25, 2023 | finance.yahoo.com

Investors in Addus HomeCare (NASDAQ:ADUS) have seen favorable returns of 54% over the past five years

See More Headlines

Receive ADUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter.

ADUS Company Calendar

Last Earnings: 7/31/2023
Today: 9/30/2023
Next Earnings (Estimated): 10/30/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Home health care services
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ADUS
CUSIP: N/A
CIK: 1468328
Web: www.addus.com
Phone: (469) 535-8200
Fax: 630-487-2707
Employees: 33,182
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $110.50
High Stock Price Forecast: $118.00
Low Stock Price Forecast: $105.00
Forecasted Upside/Downside: +29.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): $3.31
Trailing P/E Ratio: 25.74
Forward P/E Ratio: 22.54
P/E Growth: 1.76
Net Income: $46.03 million
Net Margins: 5.39%
Pretax Margin: 6.92%
Return on Equity: 9.06%
Return on Assets: 6.21%

Debt

Debt-to-Equity Ratio: 0.12
Current Ratio: 1.55
Quick Ratio: 1.55

Sales & Book Value

Annual Sales: $951.12 million
Price / Sales: 1.45
Cash Flow: $4.22 per share
Price / Cash Flow: 20.20
Book Value: $39.33 per share
Price / Book: 2.17

Miscellaneous

Outstanding Shares: 16,200,000
Free Float: 15,487,000
Market Cap: $1.38 billion
Optionable: Optionable
Beta: 0.86

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. R. Dirk Allison (Age 67)
CEO & Chairman
Comp: $1.81M

Mr. W. Bradley Bickham (Age 60)
Pres & COO
Comp: $942.47k

Mr. Brian W. Poff (Age 49)
CFO, Exec. VP, Sec. & Treasurer
Comp: $842.78k

Ms. Monica Raines (Age 44)
Exec. VP and Chief Compliance & Quality Officer
Comp: $538.17k

Mr. Cliff Blessing (Age 43)
Exec. VP & Chief Devel. Officer
Comp: $478.61k

Mr. Zach Simpson
Sr. VP & Chief Accounting Officer

Mr. Michael D. Wattenbarger (Age 53)
Exec. VP & Chief Information Officer

Mr. Sean P. Gaffney (Age 44)
Exec. VP & Chief Legal Officer

Mr. Roberton James Stevenson (Age 43)
Exec. VP & Chief Human Resource Officer

Mr. Darby Anderson (Age 57)
Exec. VP & Chief Gov. Relations Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ADUS Stock - Frequently Asked Questions

Should I buy or sell Addus HomeCare stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ADUS shares.
View ADUS analyst ratings or view top-rated stocks.
What is Addus HomeCare's stock price forecast for 2023?: 4 equities research analysts have issued 12 month target prices for Addus HomeCare's shares. Their ADUS share price forecasts range from $105.00 to $118.00. On average, they expect the company's stock price to reach $110.50 in the next year. This suggests a possible upside of 29.7% from the stock's current price.
View analysts price targets for ADUS or view top-rated stocks among Wall Street analysts.
How have ADUS shares performed in 2023?: Addus HomeCare's stock was trading at $99.49 on January 1st, 2023. Since then, ADUS shares have decreased by 14.4% and is now trading at $85.19.
View the best growth stocks for 2023 here.
Are investors shorting Addus HomeCare?: Addus HomeCare saw a increase in short interest in September. As of September 15th, there was short interest totaling 322,600 shares, an increase of 10.6% from the August 31st total of 291,700 shares. Based on an average daily volume of 96,800 shares, the days-to-cover ratio is currently 3.3 days.
View Addus HomeCare's Short Interest.
When is Addus HomeCare's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our ADUS earnings forecast.
How were Addus HomeCare's earnings last quarter?: Addus HomeCare Co. (NASDAQ:ADUS) announced its quarterly earnings results on Monday, July, 31st. The company reported $0.94 earnings per share for the quarter, beating analysts' consensus estimates of $0.87 by $0.07. The company had revenue of $259.98 million for the quarter, compared to analyst estimates of $255.56 million. Addus HomeCare had a trailing twelve-month return on equity of 9.06% and a net margin of 5.39%.
What ETFs hold Addus HomeCare's stock?: ETFs with the largest weight of Addus HomeCare (NASDAQ:ADUS) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Argent Mid Cap ETF (AMID), Invesco S&P SmallCap Health Care ETF (PSCH) and BNY Mellon Women's Opportunities ETF (BKWO).iShares U.S. Healthcare Providers ETF (IHF).

What is Dirk Allison's approval rating as Addus HomeCare's CEO?: 91 employees have rated Addus HomeCare Chief Executive Officer Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among the company's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Addus HomeCare own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and Walt Disney (DIS).
What is Addus HomeCare's stock symbol?: Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS."
How do I buy shares of Addus HomeCare?: Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Addus HomeCare's stock price today?: One share of ADUS stock can currently be purchased for approximately $85.19.
How much money does Addus HomeCare make?: Addus HomeCare (NASDAQ:ADUS) has a market capitalization of $1.38 billion and generates $951.12 million in revenue each year. The company earns $46.03 million in net income (profit) each year or $3.31 on an earnings per share basis.
How many employees does Addus HomeCare have?: The company employs 33,182 workers across the globe.
How can I contact Addus HomeCare?: Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The official website for the company is www.addus.com. The company can be reached via phone at (469) 535-8200, via email at investorrelations@addus.com, or via fax at 630-487-2707.

This page (NASDAQ:ADUS) was last updated on 9/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial